Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 934 shares at $402.95 ($376K) on 2024-05-02, disclosed to the SEC on 2024-05-03.
Scheduled sale ($376k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $402.95 | 467 | $188K | 50.0% |
| 2 | $402.95 | 467 | $188K | 50.0% |
| Total | $402.95 avg | 934 | $376K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |